By Mill Chart
Last update: Nov 28, 2024
Growth investors are on the lookout for stocks displaying robust revenue and EPS growth. In this analysis, we'll assess whether NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) aligns with growth investing criteria, especially as it consolidates and signals a possible breakout. As always, investors should conduct their own research, but NEUROCRINE BIOSCIENCES INC has surfaced on our radar for growth with base formation, warranting further examination.
ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NASDAQ:NBIX has earned a 9 for growth:
To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NASDAQ:NBIX has earned a 8 out of 10:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NASDAQ:NBIX has earned a 9 out of 10:
ChartMill incorporates a Setup Rating in its analysis, which measures the extent of consolidation in a stock over recent days and weeks. This rating, ranging from 0 to 10, is updated daily and takes into account multiple short-term technical indicators. The current setup rating for NASDAQ:NBIX is 8:
Although the technical rating is only medium, NBIX does present a nice setup opportunity. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 126.60. Right above this resistance zone may be a good entry point. We notice that large players showed an interest for NBIX in the last couple of days, which is a good sign. Very recently a Pocket Pivot signal was observed. This is another positive sign.
Our Strong Growth screener lists more Strong Growth stocks and is updated daily.
Our latest full fundamental report of NBIX contains the most current fundamental analsysis.
Check the latest full technical report of NBIX for a complete technical analysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
123.02
-0.64 (-0.52%)
Find more stocks in the Stock Screener
NEUROCRINE BIOSCIENCES (NBIX) offers strong growth, solid profitability, and reasonable valuation, making it a candidate for investors seeking affordable growth stocks in the biotech sector.
NEUROCRINE BIOSCIENCES (NBIX) shows strong growth fundamentals and a promising technical setup, making it a stock to watch for potential breakout opportunities.